NASDAQ •
Healthcare •
Biotechnology •
Quote as of 08/28/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,461.42 mln
Float143 mln
Earnings Date11/05/2026
Piotroski F-Score
2
/ 9
Weak
Beneish M-Score
-2.49
Borderline
Relative Strength
94
/ 100
Top performer
Debt / Equity
-1.56
Negative equity
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Founded in 1987 and based in Gaithersburg, Maryland, Novavax works to protect people from serious infectious diseases by bringing new vaccines to market across the United States, Europe, and beyond. Its current products include a COVID-19 vaccine and a malaria vaccine, both of which it develops and sells through partnerships with major pharmaceutical companies such as Sanofi, Pfizer, Takeda, and Serum Life Sciences.
